Strategic Research Sponsor of the American Bar Association's Section of International LawThe Queen's Award for Enterpise 2012

Features RSS

Lessons in Compliance – What Medical Devices Manufacturers Can Learn From Recent EU Enforcement Landscape

Josefine Sommer and Maurits Lugard

By Josefine Sommer and Maurits Lugard of Sidley Austin Medical devices manufacturers are braced for the overhaul of the EU Medical Devices Directives. New Regulations, which are closer to final adoption than ever (although not quite there yet), are expected to clarify the regulation of medical devices in Europe – at least once the delegated and implementing acts have been put in place.

Indirect Infringement in Pharmaceutical Patent Cases in Spain

Manuel Lobato and Marco Yago

By Manuel Lobato and Marco Yago of Bird & Bird This article intends to briefly describe two elements of indirect infringement of pharmaceutical patents that have been discussed in Spanish Courts, namely, products with a skinny label and the principle of territoriality in the article 51.1 Spanish Patent Act.

Serving It Up Sufficiently


By Nicola Dagg of Allen & Overy The requirement that a patent specification must disclose the invention in a manner that is “clear enough and complete enough for it to be performed by a person skilled in the art” (UK Patents Act/EPC) represents a significant source of commercial uncertainty for patentees. 

Increasing Focus on Claims Against Health Care Industry Representatives


By Ginger Pigott and Natassia Kwan of Greenberg Traurig As plaintiffs pursuing medical device and pharmaceutical product liability actions run into various dispositive legal defences to traditional tort claims, such as express and implied preemption, defence attorneys are seeing an increasing trend toward creative pleading in an effort to raise potential issues regarding the conduct of health care industry representatives who are either present in surgery or otherwise providing technical support to medical providers.

Life Sciences 2016: Roundtable

Who’s Who Legal brings together five leading experts to discuss issues facing life sciences lawyers and their clients today.

Regulations, Roadmaps and Recommendations


Richard Woolley, Global Restructuring Review “The absence of an international forum dealing with the resolution of sovereign debt problems has led to decisions being made across a wide range of institutional settings at the local level and at the expense of global coherence.”

UK Bar Special Report

We are pleased to present the second edition of Who’s Who Legal: UK Bar, a comprehensive guide to 24 distinct practice areas at the bar, which includes 1119 listings from 107 barristers’ chambers. This year, 11 sets are singled out for their respective strengths in our research. 

UK Bar Practice Areas

In each of our 24 chapter analyses we provide a more detailed overview of the leading silks and juniors in our research, as well as identifying the most highly regarded barristers at the bar.

Back to top

Follow us on LinkedIn

News & Features

Community News



Pro Bono

Corporate Counsel

Women in Law

Business and Human Rights

The UK Bar

Practice Areas


The Who's Who Legal 100


Special Reports



About Us

It is not possible to buy entry into any Who's Who Legal publication

Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.

Copyright © 2016 Law Business Research Ltd. All rights reserved. |

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 20 7908 1180 / Fax: +44 207 229 6910 |

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK